140
Participants
Start Date
September 30, 2014
Primary Completion Date
June 30, 2015
Study Completion Date
May 31, 2016
TEOSYAL® RHA Ultra Deep
"A sterile, biodegradable, biocompatible, viscoelastic, clear, colorless, homogenized gel implant. It consists of cross-linked hyaluronic acid produced by fermentation of Streptococcus equi bacteria, formulated to a concentration of 23 mg/mL and 0.3% w/w lidocaine in a physiologic buffer. It is supplied in individual treatment syringes with 27Gauge ½ disposable sterile needles."
United States, Beverly Hills
United States, Bradenton
United States, Chapel Hill
United States, Philadelphia
ethica Clinical Research Inc.
INDUSTRY
Teoxane SA
INDUSTRY